Gustave Roussy incarne l'espoir de guérir le cancer avant la fin du siècle.

Créée en 2005 et transformée en Fondation de recherche en 2023, la Fondation a pour mission de :

4Rs : Replication, Repair, Recombination and ROS

This team belongs to the UMR 9019 Genome Integrity and Cancers.

Medical and Scientific Library

The Medical and Scientific Library is restricted to Gustave Roussy staff. Opening hours, Monday to Friday: 9h -17h30

Collection

• 5,500 books and reference works.
• More than 4,500 electronic journals in Medicine, Science and Technology.
• Bibliographic resources: PubMed Medline, SCOPUS, ISI Web of Knowledge etc.
• Collection of surgery, radiotherapy and oncology videos to view on site.
• Collection of printed oncology journals.

Breast Diseases Committee

Head of unit - Dr Barbara Pistilli

Treatment of localized breast cancer

The treatment of patients with localized breast cancer typically involves surgery and is often complemented by additional systemic therapies such as chemotherapy, endocrine therapy, immunotherapy, targeted therapies, in addition to radiotherapy.

Pathways of care in breast pathology

Patients referred to Gustave Roussy present a spectrum of breast anomalies, ranging from benign conditions to pre-cancerous lesions and invasive tumors. Some patients do not have an established diagnosis of breast cancer or any other breast pathology, requiring both diagnosis and treatment. Others have already been diagnosed with breast cancer and are seeking treatment options or enrollment in clinical trials.

Lab members

• Saïd AOUFOUCHI – Research Scientist – Group Leader
• Dorine BONTE – Assistant professeur -Paris Sud University
• Léticia KOCH- LERNER- Post doc
• Morwenna Le GUILLOU – Engineer assistant Paris Sud University
• Céline DECAUX- Master2 trainer programm UPMC
• Charlène TRILLeaud - Master1 trainer programm UPMC
• Roukia BELGADAR Undergraduate student –UPMC

Devenez mécène de Gustave Roussy pour guérir le cancer de l’enfant et de l’adulte au 21ᵉ siècle

Chaque jour en France, plus de 400 personnes meurent d’un cancer. 

En tant qu’entreprise, vous avez le pouvoir de changer la donne pour des milliers de personnes.  Ensemble, accélérons les innovations pour changer cette réalité.